ADIPOQ and type 1 diabetes mellitus: The downregulation of adiponectin receptor expression in T1D patients is associated with the proliferation of primary CD4+ T-cells in the presence of islet lysate independent of adiponectin treatment, whereas healthy control T-cells are inhibited by adiponectin [8].